Louis Shekhtman

Bar-Ilan University — Israel

Physics and Astronomy · Physical Sciences

21h-index1.8kcitations77works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Complex Network Analysis Techniques(30), Hepatitis C virus research(24), Opinion Dynamics and Social Influence(20), Hepatitis B Virus Studies(19), Liver Disease Diagnosis and Treatment(15)

Publications77 total

Early HBV and HDV kinetics in patients undergoing liver transplantation
Digestive and Liver Disease·2025
Modeling highlights the challenge of maintaining HCV micro-elimination among people who inject drugs
2025Open Access
In-host modeling challenges using population approach methods
arXiv (Cornell University)·2025Open Access
FRI-276-YI Early kinetics of HBV and HDV serum and intrahepatic markers during and after liver transplantation: impact of HBIG and baseline HBsAg levels
Journal of Hepatology·2025
Philanthropy provides $30B annually for science and health research − funding that tends to stay local
2025
Modeling of hepatitis B virus kinetics and accumulation of cccDNA in primary human hepatocytes
JHEP Reports·2024· 6 citedOpen Access
HBV serum RNA kinetics during nucleic acid polymers based therapy predict functional cure
Antiviral Research·2024· 6 citedOpen Access
OS-063 What happens to HCV incidence after WHO elimination goal is met? Agent-based modeling predicts sustained availability of direct-acting antivirals among people who inject drugs is required to prevent returning to pre-elimination levels
Journal of Hepatology·2024
Mapping philanthropic support of science
Scientific Reports·2024· 10 citedOpen Access
Competitive funding and academic-industry collaboration: policy trends and insights
Data & Policy·2024· 5 citedOpen Access
Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations
JHEP Reports·2023· 8 citedOpen Access
Hepatitis D Virus and HBsAg Dynamics in the era of new Antiviral Treatments
Current Gastroenterology Reports·2023· 3 citedOpen Access
Acquaintance immunization with limited knowledge of network structure
New Journal of Physics·2023· 1 citedOpen Access
Philanthropy in art: locality, donor retention, and prestige
Scientific Reports·2023· 2 citedOpen Access
Rapid monophasic HBsAg decline during nucleic-acid polymer–based therapy predicts functional cure
Hepatology Communications·2023· 13 citedOpen Access
Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic
mBio·2023· 1 citedOpen Access
Modeling-based response-guided therapy with bulevirtide monotherapy for chronic hepatitis D to identify patients for finite treatment duration
Journal of Hepatology·2023· 1 cited
Percolation framework reveals limits of privacy in conspiracy, dark web, and blockchain networks
EPJ Data Science·2023· 3 citedOpen Access
Hepatitis delta virus RNA decline post inoculation in human NTCP transgenic mice is biphasic
2023· 1 citedOpen Access
Spreading of Failures in Interdependent Networks
2023· 2 cited
page 1 of 4Next →

Frequent Co-authors

Shlomo Havlin(29), Harel Dahari(13), Michael M. Danziger(11), Scott J. Cotler(10), Yehiel Berezin(5), Jingfang Fan(4), Sergey V. Buldyrev(4), Amir Bashan(4), Leeor Hershkovich(4), Michel Bazinet(4), Andrew Vaillant(4), Guido Caldarelli(3), Gaogao Dong(3), H. Eugene Stanley(3), Jianxi Gao(3), Erez Waisbard(3), Susan L. Uprichard(3), Yoav Lurie(3), Fabiana Zollo(2), Alessandro Bessi(2)